One in five Indians are vitamin D deficient, no ‘clear’ roadmap in place
HQ Team April 9, 2025: One in five Indians are Vitamin D deficient, a silent epidemic affecting 46% of children aged 0-10 years,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 9, 2025: One in five Indians are Vitamin D deficient, a silent epidemic affecting 46% of children aged 0-10 years,.
HQ Team April 9, 2025: The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40%.
Swati Mishra April 7, 2025: Multiple pregnancy, where a mother carries more than one baby in the womb, comes with its own set.
HQ Team April 6, 2025: Marathons may affect the brain causing the organ to eat itself to make up for fuel lost during.
HQ Team April 5, 2025: A recent study reveals that COVID-19 patients face increased risks of other infections for at least a year.
Becoming a doctor is not just the pinnacle of an average Indian student’s academic dreams but also a platform that bridges the status.
HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.
HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.
HQ Team April 4, 2025: Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development.
HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.